BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29792879)

  • 1. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
    Lei X; Zhang BD; Ren JG; Luo FL
    Life Sci; 2018 Aug; 206():77-83. PubMed ID: 29792879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
    Lei X; Zhang L; Li Z; Ren J
    Drug Des Devel Ther; 2018; 12():2785-2793. PubMed ID: 30233141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
    Guo H; Wang Y; Zhang X; Zang Y; Zhang Y; Wang L; Wang H; Wang Y; Cao A; Peng W
    Sci Rep; 2017 Jul; 7(1):6852. PubMed ID: 28761152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
    Wang X; Gao Y; Tian N; Zou D; Shi Y; Zhang N
    Drug Des Devel Ther; 2018; 12():2431-2442. PubMed ID: 30122901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
    Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
    Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
    Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
    Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
    Gui D; Huang J; Guo Y; Chen J; Chen Y; Xiao W; Liu X; Wang N
    Cytokine; 2013 Mar; 61(3):970-7. PubMed ID: 23434274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
    Yao T; Zha D; Gao P; Shui H; Wu X
    J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.
    Gui D; Guo Y; Wang F; Liu W; Chen J; Chen Y; Huang J; Wang N
    PLoS One; 2012; 7(6):e39824. PubMed ID: 22745830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
    Wang L; Li H
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.
    Lee SH; Yoo TH; Nam BY; Kim DK; Li JJ; Jung DS; Kwak SJ; Ryu DR; Han SH; Lee JE; Moon SJ; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1381-90. PubMed ID: 19710242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Linc 4930556M19Rik Suppresses High Glucose-Triggered Podocyte Apoptosis, Fibrosis and Inflammation via the miR-27a-3p/Metalloproteinase 3 (TIMP3) Axis in Diabetic Nephropathy.
    Fan H; Zhang W
    Med Sci Monit; 2020 Sep; 26():e925361. PubMed ID: 32896839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
    Ju Y; Su Y; Chen Q; Ma K; Ji T; Wang Z; Li W; Li W
    Biomed Pharmacother; 2019 Jan; 109():84-92. PubMed ID: 30396095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.